Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America
Commentry
Pomalidomide treatment enhances survival in myeloma patients via immune modulation
Author(s): Rao Prabhala*, Hannah Seah, Vaishnavi Bade and Srikanth Talluri
DOI:
10.37421/ 2165-7831.2024.14.323
Journal of Blood & Lymph received 443 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 